CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies

Recent studies indicate that abnormalities of the alpha-chain of the interleukin-3 receptor (IL-3RA or CD123) are frequently observed in some leukemic disorders and may contribute to the proliferative advantage of leukemic cells. This review analyzes the studies indicating that CD123 is overexpresse...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Ugo, Pelosi, Elvira, Frankel, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928610/
https://www.ncbi.nlm.nih.gov/pubmed/24513123
http://dx.doi.org/10.1186/2050-7771-2-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928610/
https://www.ncbi.nlm.nih.gov/pubmed/24513123
http://dx.doi.org/10.1186/2050-7771-2-4

Ejemplares similares